Rémi Serrano is the CEO and CFO of Pearl BioSystem, where they lead the development of innovative drug discovery services utilizing groundbreaking technology for oncology. Prior to this role, they worked as a Transition Manager at Linden RS Consulting, a Consultant at Resilab, and held various finance positions at Albemarle, Alstom, and GE, where they specialized in internal controls and financial management. Rémi holds a degree in Accounting and Finance from ESLSCA, where they continue their education.
This person is not in any teams